钙拮抗剂的全球市场规模调查&预测:药物类别，流通管道(医院，零售药局，其他)，各地区分析，2022-2029年

钙通道阻滞剂是一类通过阻止钙进入心臟和动脉细胞来降低血压的药物。

市场增长是由心血管疾病上升和口服药物需求增加等关键因素推动的。

本调查的目的是定义近年来各个细分市场和国家的市场规模，并在未来几年预测它们的价值。本报告设计内容涵盖调查对像国家产业的定性和定量双方面。

此外也提供市场未来性的成长促进因素和课题等重要方面相关之详细资讯。再加上主要企业的竞争情形和提供产品之详细分析，并涵括利害关係者投资所需的微观市场潜在机会。详细的市场区隔和子区隔如下列。

各药物类别

二氢吡啶

苯并西平

苯烷基胺

各销售管道

医院

零售药局

其他

各地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

义大利

其他欧洲

亚太地区

中国

印度

日本

澳洲

韩国

其他亚太地区

南美

巴西

墨西哥

全球其他地区

目录

第1章 摘要整理

• 市场概述
• 世界·市场区隔市场估计·预测，2019-2029年
  • 钙拮抗剂市场:各地区，2019年～2029年
  • 钙拮抗剂市场:各药物类别，2019年～2029年
  • 钙拮抗剂市场:各流通管道，2019-2029年
• 主要趋势
• 调查手法的介绍
• 调查前提条件

第2章 钙拮抗剂的全球市场:定义和范围

• 调查的目的
• 市场定义和范围
  • 调查目标范围
  • 产业的演进
• 调查对像年
• 货币换算比率

第3章 钙拮抗剂的全球市场动态

• 钙拮抗剂市场影响分析(2019-2029年)
  • 推动市场要素
  • 市场课题
  • 市场机会

第4章 钙拮抗剂的全球市场:产业分析

• 波特的5力模式
  • 供给企业谈判力
  • 买方议价能力
  • 新加入厂商业者的威胁
  • 替代品的威胁
  • 竞争企业间的敌对关係
• 波特五力分析的未来性方法(2019-2029年)
• PEST分析
  • 政治
  • 经济
  • 社会
  • 技术性
• 投资采用模式
• 分析师的结论·建议
• 顶级投资机会
• 主要成功策略

第5章 风险评估:COVID-19衝击

• COVID-19对产业带来的整体影响的评估
• COVID-19以前和COVID-19以后的市场情景

第6章 钙拮抗剂的全球市场:各药物类别

• 市场概述
• 钙拮抗剂的全球市场，各药物类别，业绩-潜在力分析
• 钙拮抗剂的全球市场，各药物类别估计·预测2019～2029年
• 钙拮抗剂市场，子区隔分析
  • 二氢吡啶
  • 苯并西平
  • 苯烷基胺

第7章 钙拮抗剂的全球市场:各流通管道

• 市场概述
• 钙拮抗剂的全球市场:各流通管道，实际成果-潜在力分析
• 钙拮抗剂的全球市场:各流通管道估计·预测2019～2029年
• 钙拮抗剂的全球市场:子区隔分析
  • 医院
  • 零售药局
  • 其他

第8章 钙拮抗剂的全球市场:各地区分析

• 钙拮抗剂市场，各地区市场概述
• 北美
  • 美国
    • 各药物类别的估计·预测，2019年～2029年
    • 各流通管道的估计·预测，2019年～2029年
  • 加拿大
• 欧洲的钙拮抗剂市场概述
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 义大利
  • 其他的欧洲地区
• 亚太地区的钙拮抗剂市场概述
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 其他亚太地区
• 南美的钙拮抗剂市场概述
  • 巴西
  • 墨西哥
• 全球其他地区

第9章 竞争资讯

• 顶级市场策略
• 企业简介
  • Bausch Health Company Inc.
    • 主要的资讯
    • 概要
    • 财务(视资料可得性)
    • 产品概要
    • 最近的开发情形
  • Abbvie Inc
  • Lupin Pharmaceuticals, Inc
  • Arbor Pharmaceuticals LLC
  • Alvogen
  • Exela Pharma Sciences, LLC
  • Covis Pharma BV
  • Novartis AG
  • GlaxoSmithKline LLC
  • Pfizer Inc

第10章 调查流程

• 调查流程
  • 资料探勘
  • 分析
  • 市场估计
  • 验证
  • 出版
• 调查属性
• 调查前提条件

Global Calcium Channel Blocker Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Calcium channel blockers are a class of drugs that lower blood pressure by stopping calcium from entering heart and artery cells. Stronger cardiac muscle contractions are caused by calcium. Calcium channel blockers facilitate this by allowing blood arteries to relax, which increases the flow of blood and ensures that the heart receives the necessary amount of oxygen. The market growth is driven by significant factors such as increase in cardiovascular diseases and rising demand for Oral Drugs.

Heart failure is a chronic, incapacitating cardio-renal-metabolic condition that affects at least 60 million people globally, according to a news release published by Boehringer Ingelheim GmbH in August 2021. There is an urgent need for novel treatment alternatives as heart failure prevalence rises. Additionally, the market is anticipated to rise due to rising hypertension rates, an increase in hospitals, and government efforts. For instance, the American Hospital Association estimates that there were 6,090 hospitals in the United States as of 2021. According to data updated by the World Health Organization (WHO) in August 2021, more than 700 million people worldwide have untreated hypertension, and as of that year, 1.28 billion people worldwide had hypertension, a sharp increase over the previous few decades. However, lack of skilled professionals' stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Calcium Channel Blocker Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is expected to hold a major market share owing to increasing prevalence rate of cardiovascular diseases. However, Asia Pacific is expected to be the fastest growing region due to large number of generic manufacturer and developing healthcare facilities.

Major market players included in this report are:

Bausch Health Company Inc.

Abbvie Inc

Lupin Pharmaceuticals, Inc

Arbor Pharmaceuticals LLC

Alvogen

Exela Pharma Sciences, LLC

Covis Pharma BV

Novartis AG

GlaxoSmithKline LLC

Pfizer Inc

Recent Developments in the Market:

• The FDA approved Norliqva (amlodipine) oral solution in February 2022 to treatment hypertension in adults and children aged 6 and older, as well as to prevent coronary artery disease.
• The American Food and Drug Administration (FDA) received provisional permission in May 2022 for Zydus Worldwide DMCC's subsidiary to commercialize Selexipag tablets for the treatment of pulmonary arterial hypertension (PAH) in adults.

Global Calcium Channel Blocker Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug Class, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Dihydropyridine

Benzothizepine

Phenylalkylamine

By Distribution Channel:

Hospitals

Retail Pharmacies

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Calcium Channel Blocker Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Calcium Channel Blocker Market, by Drug Class, 2019-2029 (USD Billion)
  • 1.2.3. Calcium Channel Blocker Market, by Distribution Channel, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Calcium Channel Blocker Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Calcium Channel Blocker Market Dynamics

• 3.1. Calcium Channel Blocker Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increase in Cardiovascular Diseases
    • 3.1.1.2. Rising demand for oral drugs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of skilled professionals
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing demand for retail pharmacies
    • 3.1.3.2. Increased clinical studies and government initiatives

Chapter 4. Global Calcium Channel Blocker Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Calcium Channel Blocker Market, by Drug Class

• 6.1. Market Snapshot
• 6.2. Global Calcium Channel Blocker Market by Drug Class, Performance - Potential Analysis
• 6.3. Global Calcium Channel Blocker Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
• 6.4. Calcium Channel Blocker Market, Sub Segment Analysis
  • 6.4.1. Dihydropyridine
  • 6.4.2. Benzothizepine
  • 6.4.3. Phenylalkylamine

Chapter 7. Global Calcium Channel Blocker Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Calcium Channel Blocker Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Calcium Channel Blocker Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
• 7.4. Calcium Channel Blocker Market, Sub Segment Analysis
  • 7.4.1. Hospitals
  • 7.4.2. Retail Pharmacies
  • 7.4.3. Others

Chapter 8. Global Calcium Channel Blocker Market, Regional Analysis

• 8.1. Calcium Channel Blocker Market, Regional Market Snapshot
• 8.2. North America Calcium Channel Blocker Market
  • 8.2.1. U.S. Calcium Channel Blocker Market
    • 8.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Calcium Channel Blocker Market
• 8.3. Europe Calcium Channel Blocker Market Snapshot
  • 8.3.1. U.K. Calcium Channel Blocker Market
  • 8.3.2. Germany Calcium Channel Blocker Market
  • 8.3.3. France Calcium Channel Blocker Market
  • 8.3.4. Spain Calcium Channel Blocker Market
  • 8.3.5. Italy Calcium Channel Blocker Market
  • 8.3.6. Rest of Europe Calcium Channel Blocker Market
• 8.4. Asia-Pacific Calcium Channel Blocker Market Snapshot
  • 8.4.1. China Calcium Channel Blocker Market
  • 8.4.2. India Calcium Channel Blocker Market
  • 8.4.3. Japan Calcium Channel Blocker Market
  • 8.4.4. Australia Calcium Channel Blocker Market
  • 8.4.5. South Korea Calcium Channel Blocker Market
  • 8.4.6. Rest of Asia Pacific Calcium Channel Blocker Market
• 8.5. Latin America Calcium Channel Blocker Market Snapshot
  • 8.5.1. Brazil Calcium Channel Blocker Market
  • 8.5.2. Mexico Calcium Channel Blocker Market
• 8.6. Rest of The World Calcium Channel Blocker Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Bausch Health Company Inc.
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Abbvie Inc
  • 9.2.3. Lupin Pharmaceuticals, Inc
  • 9.2.4. Arbor Pharmaceuticals LLC
  • 9.2.5. Alvogen
  • 9.2.6. Exela Pharma Sciences, LLC
  • 9.2.7. Covis Pharma BV
  • 9.2.8. Novartis AG
  • 9.2.9. GlaxoSmithKline LLC
  • 9.2.10. Pfizer Inc

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Calcium Channel Blocker Market, report scope
• TABLE 2. Global Calcium Channel Blocker Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Calcium Channel Blocker Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
• TABLE 4. Global Calcium Channel Blocker Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
• TABLE 5. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Calcium Channel Blocker Market
• TABLE 70. List of primary sources, used in the study of global Calcium Channel Blocker Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Calcium Channel Blocker Market, research methodology
• FIG 2. Global Calcium Channel Blocker Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Calcium Channel Blocker Market, key trends 2021
• FIG 5. Global Calcium Channel Blocker Market, growth prospects 2022-2029
• FIG 6. Global Calcium Channel Blocker Market, porters 5 force model
• FIG 7. Global Calcium Channel Blocker Market, pest analysis
• FIG 8. Global Calcium Channel Blocker Market, value chain analysis
• FIG 9. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Calcium Channel Blocker Market, regional snapshot 2019 & 2029
• FIG 15. North America Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
• FIG 19. Global Calcium Channel Blocker Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable